Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Cash from Investing Activities came in at -$26.6 million in Q2 2026, down 110.2% year-on-year from $260.7 million in Q2 2025, and up 97.09% quarter-over-quarter from -$914.5 million in Q1 2026.
Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$26.6 million for Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 110.2% year-over-year to -$26.6 million in Q2 2026; TTM through Jun 2026 was -$749.5 million, a 65.98% increase from a year earlier, with the FY2025 full-year figure at $665.8 million, up 120.34% from the prior year.
- Cash from Investing Activities grew to -$26.6 million in Q2 2026 per ISRG's latest filing, from -$914.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $574.8 million in Q4 2022 and bottomed at -$1.4 billion in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$77.6 million (2024), against an average of -$141.0 million.
- Across the five-year window, Cash from Investing Activities jumped 366.93% in 2023 and slumped 528.34% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at $574.8 million in 2022, then slumped by 281.66% to -$1.0 billion in 2023, then declined by 21.07% to -$1.3 billion in 2024, then soared by 83.44% to -$209.4 million in 2025, then jumped by 87.3% to -$26.6 million in 2026.
- Per Business Quant, the three latest ISRG Cash from Investing Activities figures stand at -$26.6 million (Q2 2026), -$914.5 million (Q1 2026), and -$209.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.60 Mn |
| Jun 30, 2026 | -26.60 Mn |
| Mar 31, 2026 | -914.50 Mn |
| Mar 31, 2026 | -914.50 Mn |
| Dec 31, 2025 | -209.40 Mn |
| Dec 31, 2025 | -209.40 Mn |
| Sep 30, 2025 | 401.00 Mn |
| Sep 30, 2025 | 401.00 Mn |
| Jun 30, 2025 | 260.70 Mn |
| Jun 30, 2025 | 260.70 Mn |
| Mar 31, 2025 | 213.50 Mn |
| Mar 31, 2025 | 213.50 Mn |
| Dec 31, 2024 | -1.26 Bn |
| Dec 31, 2024 | -1.26 Bn |
| Sep 30, 2024 | -1.41 Bn |
| Sep 30, 2024 | -1.41 Bn |
| Jun 30, 2024 | -467.10 Mn |
| Jun 30, 2024 | -467.10 Mn |
| Mar 31, 2024 | -128.50 Mn |
| Mar 31, 2024 | -128.50 Mn |